arrow
T

Tomonori Yano

National Cancer Center
H指数:43
被引数:7,316

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a Multimodal AI Model to Predict the Efficacy of Photodynamic Therapy for Local Residual or Recurrent Lesions Following Chemoradiotherapy or Radiotherapy for Esophageal Cancer

开发一种多模态AI模型以预测食管癌放化疗或放疗后局部残留或复发病灶的光动力治疗效果

2026-10-070
PRE
Author's Reply: Neutrophil-Macrophage Interactions in Gastric Cancer

作者回复:中性粒细胞-巨噬细胞相互作用在胃癌中的作用

2026-08-250
OAAI
Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan

食管内镜黏膜下剥离术治疗鳞状细胞癌患者术后出血风险:一项日本多中心回顾性研究(抗血小板治疗患者)

2026-08-150
PRE
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer

cDC1-NK/T-恶性细胞回路在PD-1阻断下驱动胃癌的免疫原性重塑

2026-05-210
OAAI
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy

中性粒细胞-巨噬细胞相互作用塑造化疗免疫治疗期间胃癌中炎症巨噬细胞的重塑

2026-05-210
OAAI
Transgelin Expression in Activated Cancer-Associated Fibroblasts Regulates Stromal Contractility and Promotes Colon Cancer Progression

激活的癌症相关成纤维细胞中Transgelin的表达调控基质收缩性并促进结肠癌进展

2026-04-080
OAAI
An open label phase II study of total neoadjuvant therapy (TNT) consisting of FLOT with pembrolizumab and short radiation for patients with locally advanced gastroesophageal junction adenocarcinoma (EPOC2301)

一项开放标签的II期研究,评估总新辅助疗法(TNT)在局部晚期胃食管结合部腺癌患者中的应用,该疗法包括FLOT联合pembrolizumab和短程放疗(EPOC2301)。

2025-12-010
OA
Objective Assessment of Visibility of Colorectal Lesions Using Eye Tracking for New Image-Enhanced Endoscopy Observation

使用眼动追踪对新型图像增强内镜观察下结直肠病变可见性的客观评估

2025-12-010
OAAI
Outcomes of endoscopic submucosal dissection for locally recurrent early gastric cancer after endoscopic resection: analysis of a multicenter prospective cohort study

内镜下黏膜下剥离术治疗内镜切除术后局部复发的早期胃癌的疗效:一项多中心前瞻性队列研究分析

2025-11-150
PRE
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer

CLDN18.2阳性胃癌患者接受含zolbetuximab化疗期间早期胃炎的特征分析

2025-09-300
OAAI
Clinical Outcomes and Prognostic Factors in Patients Undergoing Salvage Endoscopic Therapy for cT1N0M0 Local Failure After Chemoradiotherapy for Esophageal Cancer: A Multicenter Retrospective Study

临床结局与预后因素:接受挽救性内镜治疗的cT1N0M0食管癌放化疗后局部复发患者:一项多中心回顾性研究

2025-09-100
PRE
Artificial Intelligence in Gastrointestinal Endoscopy: The Japan Gastroenterological Endoscopy Society Position Statements

人工智能在消化道内镜中的应用:日本消化内镜学会立场声明

2025-06-300
PRE
Short- and long-term outcomes of endoscopic resection for gastric tube cancer: a Japanese multicenter prospective cohort study

内镜下切除治疗胃管癌的短期与长期预后:一项日本多中心前瞻性队列研究

2025-04-080
PRE
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010) (vol 24, pg 479, 2020)
2025-02-130
OA
Comparison of outcomes between surgery and chemoradiotherapy after endoscopic resection for pT1a-MM with lymphovascular invasion or pT1b esophageal squamous cell carcinoma: Japanese multicenter propensity score-matched study
2024-12-030
OAAI
Possibility of determining high quantitative fecal occult blood on stool surface using hyperspectral imaging
2024-10-230
OAAI